Pardes Biosciences, Inc.
PRDS
$0.02
Change (1 day)
$3.67
Year High
$0.75
Year Low
Categories
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases. The company was incorporated in 2020 and is headquartered in Carlsbad, California.
Earnings for Pardes Biosciences, Inc. (PRDS)
Earnings in 2022 (TTM): $-96,634,000
According to Pardes Biosciences, Inc.'s latest financial reports the company's current earnings (TTM) are $-96,634,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Pardes Biosciences, Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2022 | $-96,634,000 | $-93,451,000 |
| 2021 | $-38,518,000 | $-38,548,000 |